PROCESS FOR DETERMINING CONTENT OF PHARMACEUTICALLY ACTIVE MATERIALS IN BODY LIQUIDES AND PROCESS FOR PRODUCING KIT FOR THEM

摘要

the invention is in accordance with the procedure laid down hatu00e9ku0151ny, uh, therapeutically benzu0151diazepin - 2,3 - szu00e1rmazu00e9ku0151k,benzyl izu0151kinu0151lin - szu00e1rmazu00e9ku0151k and aktu00edvmetabu0151litjaik ku0151ncentru00e1ciu00f3ju00e1t hatu00e1ru0151zzu00e1k and testfu0151lyadu00e9ku0151kban (in particular, plasma u0151ly mu00f3du0151n), hu0151gy radiu0151aktu00edv 2,3 - benzu0151diazepin ligand 2,3 - benzu0151diazepin binding site is present in the active substance of the atestfu0151lyadu00e9kban by medical tu00f6rtu00e9nu0151gu00e1tlu00e1su00e1t is measured.the invention can be used in the above vu0151natku0151zik tu0151vu00e1bbu00e1 elju00e1ru00e1selvu00e9gzu00e9su00e9re diagnu0151sztikai stock, which is at least egyradiu0151aktu00edv 2,3 - benzu0151diazepin - ligandu0151t, 2,3 - benzu0151diazepin - ku00f6tu0151helyetu00e9s standarddon't radiu0151aktu00edv 2,3 - benzu0151diazepin - ligandu0151t contains. a